You are here

Article Text

Article menu

Download PDFPDF

Ovarian cancer
93 Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients. A survey from MITO-ManGO Groups
Free
  1. S Greggi1,
  2. F Bifulco2,
  3. A Ferrero3,
  4. P Zola4,
  5. E Busato5,
  6. N Biglia6,
  7. M Stefanetti7,
  8. S Danese8,
  9. G Valabrega9 and
  10. F Falcone1
  1. 1Istituto Nazionale Tumori, IRCSS, “Fondazione G. Pascale”, Department of Gynecologic Oncology, Italy
  2. 2Istituto Nazionale Tumori, IRCSS, “Fondazione G. Pascale”, Division of Anesthesia and Pain Medicine, Italy
  3. 3Mauriziano Hospital, Academic Department Gynaecology and Obstetrics, Italy
  4. 4University of Turin, Department of Surgical Sciences, Italy
  5. 5Treviso Regional Hospital, Department of Obstetrics and Gynecology, Italy
  6. 6Umberto I Hospital, Division of Gynecology and Obstetrics, Italy
  7. 7Infermi Hospital, Obstetrics and Gynecology, Italy
  8. 8University of Turin, Città della Salute e della Scienza, Gynecology and Obstetrics, Italy
  9. 9Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Department of Oncology, Italy

Abstract

Introduction/Background*Enhanced Recovery After Surgery (ERAS) is currently considered as a global surgical quality improvement initiative. There is a paucity of data, however, concerning its application in advanced ovarian cancer (AOC) patients. The present analysis shows the results of a survey aimed at gathering detailed information on current perioperative management of AOC patients within MITO-ManGO Groups.

Methodology A 60-item questionnaire, covering the ERAS items for perioperative care in cytoreductive surgery, was sent to the responsible for each MITO/ManGO centre. Only questionnaires from centres reporting to operate >20 AOC per year were considered for the present analysis.

Result(s)*Thirty/30 (100%) questionnaires from eligible centres were analysed. Survey main outcomes were presented and compared with the recommendations from the ERAS Society in table 1. Figure 1 graphically shows concordance between centres’ current behaviour and ERAS recommendations, expressed by rate of concordance. In particular, ≥70% concordance (rate of centres behaving in agreement with ERAS recommendations) was observed in 2/10, 8/12, and 5/9 items, respectively for the pre, intra and postoperative phase.

Abstract 93 Figure 1
Abstract 93 Figure 1

Concordance between centres‘ behaviour and ERAS recommendations, expressed by rate of centres behaving in agreement with ERAS recommendations (agreement green; disagreement : red)

View this table:
Abstract 93 Table 1

Survey outcomes compared with the recommendations from the ERAS society

Conclusion*Although the recent attempts by the health providers to improve the management of AOC patients, this survey shows that further efforts should be made in order to optimize the perioperative pathway. This is true even in selected centres belonging to national oncological networks. There is a need for a structured peri-operative program specifically targeting AOC patients candidate to cytoreductive surgery.

https://doi.org/10.1136/ijgc-2021-ESGO.338

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.